MyD88 assumes multifaceted, pivotal roles in the landscape of breast cancer, influencing diverse aspects such as tumor development, drug resistance, stem cell properties, and the intricacies of the immune microenvironment. This evidence concerns the gene MYD88 and neoplasm.